Volume 12, Number 8—August 2006
Research
Antibody Response to Pneumocystis jirovecii
Table 1
Characteristic | PCP (n = 80) | Controls (n = 41) | ||
---|---|---|---|---|
Demographic | ||||
Male (%) | 86 | 76 | ||
Race (%) | ||||
Caucasian | 55 | 39 | ||
African American | 29 | 39 | ||
Other | 16 | 22 | ||
Age at enrollment (y) | 41 ± 8 | 42 ± 8 | ||
Clinical | ||||
CD4 count (cells/μL)†‡ | 29 ± 3 | 73 ± 4 | ||
Plasma HIV RNA (copies/mL)†‡ | 123,130 ± 5 | 15,582 ± 24 | ||
Albumin (g/L) | 3.0 ± 0.5 | 3.1 ± 0.7 | ||
Prior PCP (%) | 24 | 33 | ||
Pneumonia severity | ||||
pO2 (mm Hg) | 65 ± 15.6 | 73 ± 29 | ||
Aa gradient (mm Hg) | 44 ± 13 | 41 ± 15 | ||
LDH (U/L)†‡ | 359 ± 2 | 257 ± 2 | ||
Mechanical ventilation (%) | 7 | 7 | ||
Serum antibody levels | ||||
MsgA† | 5.6 ± 4.8 | 3.7 ± 3.5 | ||
MsgB† | 2.9 ± 1.3 | 1.9 ± 0.9 | ||
MsgC† | 4.2 ± 4.3 | 4.3 ± 3.4 |
*Unless specified otherwise, values are mean ± standard deviation. pO2, oxygen pressure; Aa, alveolar-arterial; LDH, lactate dehydrogenase; Msg, major surface glycoprotein.
†Geometric mean ± geometric standard deviation.
‡Significant difference between patient groups for CD4+ count (p<0.01), plasma HIV RNA (p<0.001), LDH (p<0.001).
Page created: December 09, 2011
Page updated: December 09, 2011
Page reviewed: December 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.